☆ 3.9 Article

Septic Shock after Seasonal Influenza Vaccination in an HIV-Infected Patient during Treatment with Etanercept for Rheumatoid Arthritis: a Case Report

CLINICAL AND VACCINE IMMUNOLOGY (2013)

期刊

CLINICAL AND VACCINE IMMUNOLOGY

卷 20, 期 5, 页码 761-764

出版社

AMER SOC MICROBIOLOGY

DOI: 10.1128/CVI.00081-13

关键词

-

类别

Immunology Infectious Diseases Microbiology

向作者/读者索取更多资源

Protocol

Reagent

摘要

Anti-tumor necrosis factor alpha (anti-TNF-alpha) is used in the treatment of rheumatic diseases not responsive to first-line regimens. Data on the safety of anti-TNF-alpha in HIV-infected patients are scarce and conflicting. We describe a case of septic shock and multiorgan failure that occurred after etanercept initiation and influenza vaccination in an HIV-infected woman with rheumatoid arthritis.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Biotechnology & Applied Microbiology

Analysis of protective immune responses to seasonal influenza vaccination in HIV-infected individuals

Ying Xia, Fuli Mi, Guoqiang Du, Shenghui Qin

Summary: This study investigated the immune response in HIV+ individuals receiving ART treatment after seasonal influenza vaccination. The findings revealed an increase in proliferation of CD4+T cells and B cells one week post-vaccination, which correlated with influenza-specific H1N1 Nab at day 28. The study also showed an inverse correlation between apoptosis of CD4+T cells and B cells at day 7 and influenza-specific H1N1 Nab.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

添加到收藏夹

Article Immunology

Immunodominance hierarchy after seasonal influenza vaccination

Laura Sanchez-de Prada, Ivan Sanz-Munoz, Raul Ortiz de Lejarazu, Jose Maria Eiros, Adolfo Garcia-Sastre, Teresa Aydillo

Summary: Current influenza vaccines induce humoral immune responses against the HA protein, with Sb and Ca2 antigenic sites showing high immunodominance. Elderly individuals have lower pre-vaccination antibody levels, while young adults have lower levels only at the Sb and Ca2 sites. After vaccination, ATIV reduces humoral responses to all viruses, while QIV only reduces responses to Sb and Ca2.

EMERGING MICROBES & INFECTIONS (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Structural inequities in seasonal influenza vaccination rates

Lara I. Brewer, Mark J. Ommerborn, Augustina Le Nguyen, Cheryl R. Clark

Summary: Structural inequities contribute to low influenza vaccination rates in the United States, with non-Hispanic White and Asian individuals having higher vaccination rates. Lack of health insurance, regular access to primary care, and delaying medical care due to cost were predictive factors for lower vaccination rates.

BMC PUBLIC HEALTH (2021)

添加到收藏夹

Article Immunology

Severe influenza infection is associated with inflammatory programmed cell death in infected macrophages

Andre C. Ferreira, Carolina Q. Sacramento, Filipe S. Pereira-Dutra, Natalia Fintelman-Rodrigues, Priscila P. Silva, Mayara Mattos, Caroline S. de Freitas, Andressa Marttorelli, Gabrielle R. de Melo, Mariana M. Campos, Isaclaudia G. Azevedo-Quintanilha, Aluana S. Carlos, Joao Vitor Emidio, Cristiana C. Garcia, Patricia T. Bozza, Fernando A. Bozza, Thiago M. L. Souza

Summary: This study found that influenza virus infection can induce inflammatory programmed cell death in macrophages, and inhibiting inflammatory cell death can reduce inflammation and lung injury. This study identified an additional mechanism involved in severe influenza and proposed a clinically available method for treatment.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2023)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Knowledge and attitudes about influenza vaccination in rheumatic diseases patients

Gabriel Figueroa-Parra, Jorge Antonio Esquivel-Valerio, Leticia Santoyo-Fexas, Andrea Moreno-Salinas, Carmen Magdalena Gamboa-Alonso, Ana Laura De Leon-Ibarra, Dionicio Angel Galarza-Delgado

Summary: This study investigated the knowledge and attitudes about influenza vaccination among patients with rheumatic diseases and found that concerns about safety, efficacy, side effects, fear of the vaccine, and knowledge of cost can diminish vaccine uptake. These factors are related to confidence, complacency, and convenience as components of vaccine hesitancy in this population.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

添加到收藏夹

Article Immunology

Humoral immune response following the inactivated quadrivalent influenza vaccination among HIV-infected and HIV-uninfected adults

Zhaozhen Liu, Can Pang, Yuchuan Deng, Caiping Guo, Jia Li, Yanping Li, Ruolei Xin, Xiyao Li, Conghui Xu, Chun Huang, Hongyan Lu, Jie Li

Summary: This study investigated the immunogenicity of the quadrivalent inactivated influenza vaccine in HIV-infected and uninfected individuals, and found that HIV-infected individuals had weaker immune responses, especially those with CD4+ T cell counts below 350 cells/mm3.

VACCINE (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

Efficacy, safety and immunogenicity of etanercept biosimilars versus reference biologics in patients with rheumatoid arthritis: A meta-analysis

Rui Hu, Tao Yuan, Hui Wang, Jianglin Zhao, Liya Shi, Quankai Li, Chunmei Zhu, Na Su, Shengzhao Zhang

Summary: This meta-analysis found that etanercept biosimilars were more effective than reference biologics (Enbrel) in terms of ACR50 response rate for treating active rheumatoid arthritis, while other outcomes related to efficacy, safety, and immunogenicity were comparable between etanercept biosimilars and the originator.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Immunology

Relationship between Humoral Response in COVID-19 and Seasonal Influenza Vaccination

Barbara Poniedzialek, Ewelina Hallmann, Dominika Sikora, Karol Szymanski, Katarzyna Kondratiuk, Jakub Zurawski, Piotr Rzymski, Lidia Brydak

Summary: Evidence suggests that vaccination against seasonal influenza can enhance innate immune responses to COVID-19 and reduce disease severity. This study aimed to compare humoral responses to SARS-CoV-2 in non-hospitalized, COVID-19 unvaccinated patients and mild COVID-19 convalescent patients who were and were not vaccinated against influenza. The results showed that influenza-vaccinated patients had higher levels of antibodies against nucleocapsid and receptor binding domain compared to non-vaccinated patients.

VACCINES (2022)

添加到收藏夹

Article Immunology

Restoration of Default Blood Monocyte-Derived Macrophage Polarization With Adalimumab But Not Etanercept in Rheumatoid Arthritis

Audrey Paoletti, Bineta Ly, Samuel Bitoun, Gaetane Nocturne, Elodie Riviere, Jessica J. Manson, Andrea Matucci, Marc Pallardy, Niek De Vries, Xavier Mariette

Summary: This longitudinal study demonstrates that ADA but not ETA is able to restore the M2-like polarization of monocytes that is defective in RA.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Post-switch Effectiveness of Etanercept Biosimilar Versus Continued Etanercept in Rheumatoid Arthritis Patients with Stable Disease: A Prospective Multinational Observational Study

Janet Pope, Stephen Hall, Claire Bombardier, Boulos Haraoui, Graeme Jones, Latha Naik, Carol J. Etzel, Dena R. Ramey, Ricardo Infante, Maia Miguelez, Stephanie Falcao, Sevag Sahakian, David Wu

Summary: This study evaluated the effectiveness of the voluntary switch from originator (etanercept, ETN) to etanercept biosimilar (SB4) in patients with stable rheumatoid arthritis (RA). The results showed that SB4 demonstrated comparable effectiveness to ETN in patients with stable RA who voluntarily switched to the biosimilar in a real-world setting.

ADVANCES IN THERAPY (2022)

添加到收藏夹

Article Immunology

Ancillary benefits of seasonal influenza vaccination in middle-income countries

Malembe S. Ebama, Susan Y. Chu, Eduardo Azziz-Baumgartner, Kathryn E. Lafond, Margaret McCarron, Stephen C. Hadler, Rachael M. Porter, Mark McKinlay, Joseph Bresee

Summary: Implementing seasonal influenza vaccines not only reduces diseases but also improves attitudes towards vaccines among risk groups, increases demand, and enhances collaboration with other sectors and mass media. However, challenges such as sustaining investment, vaccine supply, and campaign management still exist.

VACCINE (2021)

添加到收藏夹

Article Immunology

Motivating Seasonal Influenza Vaccination and Cross-Promoting COVID-19 Vaccination: An Audience Segmentation Study among University Students

Daisy Lee, Sharyn Rundle-Thiele, Gabriel Li

Summary: This study identifies distinct and homogeneous groups of university students in relation to their attitudes, behaviors, intentions, and responses to promotion messages about seasonal influenza and COVID-19 vaccination through two-step cluster analysis. Findings reveal four segments with significant differences, providing insights for developing tailored vaccination programs for university students. This tailored approach aims to increase vaccination rates and promote the uptake of COVID-19 vaccines among this population.

VACCINES (2021)

添加到收藏夹

Article Infectious Diseases

Costs of seasonal influenza vaccination in South Africa

Heather Fraser, Winfrida Tombe-Mdewa, Ciaran Kohli-Lynch, Karen Hofnnan, Stefano Tennpia, Meredith McMorrow, Philipp Lambach, Wayne Ramkrishna, Cheryl Cohen, Raymond Hutubessy, Ijeoma Edoka

Summary: The South African National Department of Health introduced a trivalent inactivated influenza vaccination programme in 2010 to address the burden of influenza. By estimating the costs and conducting scenario analyses, we provide estimates of the total costs of the programme, which can serve as a basis for future programme expansion and cost-effectiveness analyses.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2022)

添加到收藏夹

Article Economics

Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany

Stefan M. Scholz, Felix Weidemann, Oliver Damm, Bernhard Ultsch, Wolfgang Greiner, Ole Wichmann

Summary: The study finds that vaccinating 2 to 9-year-olds with quadrivalent influenza vaccines is cost-saving in Germany, and extending the target group to 2 to 17-year-olds can increase health benefits. Even without vaccine-induced herd protection, childhood vaccination against seasonal influenza remains cost-effective.

VALUE IN HEALTH (2021)

添加到收藏夹

Article Medicine, General & Internal

Polyarticular Haemophilus Influenza Septic Arthritis in an HIV Patient

Taha Faruqi, Adam Green, Daniel P. McCall, Matthew Caid, Logan C. Smith

Summary: Haemophilus influenzae is a gram-negative bacterium commonly found in the upper respiratory tract of humans. While vaccines have helped suppress infections caused by these bacteria, immunocompromised individuals may still be at risk for invasive Haemophilus infections, particularly within the musculoskeletal system. Early recognition and treatment with surgical intervention and antibiotics are crucial in the management of these infections to prevent complications.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Capabilities of global high-level isolation units: A pre-workshop survey

Jocelyn J. Herstein, Timo Wolf, Emanuele Nicastri, Yee Sin Leo, Poh Lian Lim, Michael Jacobs, Sharon Vanairsdale, Eric Toner, Matthew P. Shearer, Angela Vasa, Vikram Mukherjee, Andrea Echeverri, Erica S. Shenoy, John J. Lowe

Summary: The survey aimed to assess the experience, physical infrastructure, and capabilities of high-level isolation units planning to participate in a 2018 global workshop. Results showed variation in unit infrastructure, capabilities, and procedures, highlighting the diversity of HLIUs approaches. Collaboration among HLIUs is essential to define best practices for the design and development of such units.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)

添加到收藏夹

Letter Pathology

Post-mortem differential diagnosis from COVID-19: A case of fulminant myocarditis HHV-6 related

Daniele Colombo, Camilla Cecannecchia, Marco Albore, Fabrizio Taglietti, Roberta Nardacci, Giorgio Bolino, Franca Del Nonno

PATHOLOGY INTERNATIONAL (2022)

添加到收藏夹

Article Medicine, General & Internal

Aero-Medical Evacuation during SARS-CoV-2 Pandemic: Extraordinary Measure or Emerging Treatment Option?

Domenico Benvenuto, Tommaso Ascoli Bartoli, Ambrogio Curtolo, Claudia Palazzolo, Serena Vita, Andrea Mariano, Laura Scorzolini, Giuseppe Ippolito, Luisa Marchioni, Federico Cerini, Gianpiero D'Offizi, Francesco Vaia, Emanuele Nicastri

Summary: Aero-medical evacuation is a feasible and safe treatment option during the COVID-19 pandemic, especially for patients with complex cases and coinfections.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Infectious Diseases

The possible effect of sociobehavioral factors and public health actions on the mpox epidemic slowdown

Francesco Vairo, Sara Leone, Valentina Mazzotta, Pierluca Piselli, Gabriella De Carli, Simone Lanini, Fabrizio Maggi, Emanuele Nicastri, Roberta Gagliardini, Serena Vita, Andrea Siddu, Giovanni Rezza, Alessandra Barca, Francesco Vaia, Andrea Antinori, Enrico Girardi

Summary: A pre-exposure vaccination campaign was initiated in Italy in August 2022 to prevent the spread of mpox virus. This study explores the factors affecting the trend of mpox cases in the Lazio region of Italy, which had a rapid roll-out of the vaccination campaign, through a Poisson segmented regression model.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant

Licia Bordi, Giuseppe Sberna, Eleonora Lalle, Lavinia Fabeni, Valentina Mazzotta, Simone Lanini, Angela Corpolongo, Anna Rosa Garbuglia, Emanuele Nicastri, Enrico Girardi, Francesco Vaia, Andrea Antinori, Fabrizio Maggi

Summary: The study compared the detection of the SARS-CoV-2 Omicron variant in nasopharyngeal-swab (NPS) and oral saliva samples. Results showed good agreement between the two types of samples, with a significant correlation among cycle threshold values. The study also found that saliva can be used as an alternative specimen for the detection and follow-up of Omicron-infected patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose

Serena Ruggieri, Alessandra Aiello, Carla Tortorella, Assunta Navarra, Valentina Vanini, Silvia Meschi, Daniele Lapa, Shalom Haggiag, Luca Prosperini, Gilda Cuzzi, Andrea Salmi, Maria Esmeralda Quartuccio, Anna Maria Gerarda Altera, Anna Rosa Garbuglia, Tommaso Ascoli Bartoli, Simonetta Galgani, Stefania Notari, Chiara Agrati, Vincenzo Puro, Emanuele Nicastri, Claudio Gasperini, Delia Goletti

Summary: This study investigated the antibody and T-cell immune responses in multiple sclerosis patients (PwMS) undergoing different disease-modifying treatments (DMTs) after receiving the two-dose schedule of a COVID-19 mRNA vaccine. The results showed a significant decrease in seroconversion rate and anti-receptor-binding domain (RBD)-IgG titers from the first dose to 24 weeks later, and a significant increase after the booster dose. The booster dose improved both humoral and cell-mediated immune responses, especially in PwMS, highlighting the need for tailored strategies for immunocompromised patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Infectious Diseases

A Cholera Case Imported from Bangladesh to Italy: Clinico-Epidemiological Management and Molecular Characterization in a Non-Endemic Country

Valeria Russini, Maria Letizia Giancola, Grazia Brunetti, Carmela Calbi, Elena Anzivino, Carla Nisii, Lucia Scaramella, Anna Maria Dionisi, Francesca Faraglia, Marina Selleri, Laura Villa, Sarah Lovari, Maria Laura De Marchis, Teresa Bossu, Francesco Vairo, Adolfo Pagnanelli, Emanuele Nicastri

Summary: Despite the global cholera outbreaks, returning European travelers have only reported few cases. The study presents a case of a 41-year-old male returning to Italy from Bangladesh with watery diarrhea. The patient's stools were tested positive for Vibrio cholerae and norovirus. Whole genome sequencing and bioinformatics analysis revealed the strain belonged to ST69 and was related to a 2018 outbreak in Dhaka, Bangladesh. The multidisciplinary approach adopted ensured rapid and accurate diagnosis, clinical management, and epidemiological investigation.

TROPICAL MEDICINE AND INFECTIOUS DISEASE (2023)

添加到收藏夹

Letter Medicine, General & Internal

Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19

Daniele Focosi, Emanuele Nicastri

ANNALS OF INTERNAL MEDICINE (2023)

添加到收藏夹

Letter Immunology

Convalescent Plasma Versus Hyperimmune Immunoglobulins

Daniele Focosi, Massimo Franchini, Emanuele Nicastri, David J. Sullivan, Arturo Casadevall

CLINICAL INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Immunology

Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine

Andrea Picchianti-Diamanti, Assunta Navarra, Alessandra Aiello, Bruno Lagana, Gilda Cuzzi, Andrea Salmi, Valentina Vanini, Fabrizio Maggi, Silvia Meschi, Giulia Matusali, Stefania Notari, Chiara Agrati, Simonetta Salemi, Roberta Di Rosa, Damiano Passarini, Valeria Di Gioia, Giorgio Sesti, Fabrizio Conti, Francesca Romana Spinelli, Angela Corpolongo, Maria Sole Chimenti, Mario Ferraioli, Gian Domenico Sebastiani, Maurizio Benucci, Francesca Li Gobbi, Anna Paola Santoro, Andrea Capri, Vincenzo Puro, Emanuele Nicastri, Delia Goletti

Summary: Breakthrough infections (BIs) in rheumatoid arthritis (RA) patients after a COVID-19 vaccination booster dose were analyzed. Older age, receiving conventional synthetic disease modifying antirheumatic drugs (csDMARDs), and higher neutralising antibody titres were identified as protective factors, while anti-IL6R treatment and anti-CD20 therapy increased the risk. The incidence of hospitalization for BIs was significantly higher in RA patients compared to healthcare workers.

VACCINES (2023)

添加到收藏夹

Article Immunology

Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination

Giulia Matusali, Elisa Petruccioli, Eleonora Cimini, Francesca Colavita, Aurora Bettini, Eleonora Tartaglia, Settimia Sbarra, Silvia Meschi, Daniele Lapa, Massimo Francalancia, Licia Bordi, Valentina Mazzotta, Sabrina Coen, Klizia Mizzoni, Alessia Beccacece, Emanuele Nicastri, Luca Pierelli, Andrea Antinori, Enrico Girardi, Francesco Vaia, Alessandro Sette, Alba Grifoni, Delia Goletti, Vincenzo Puro, Fabrizio Maggi

Summary: This study found that a high proportion of individuals who received the smallpox vaccine 40 to 60 years ago have humoral cross-immunity to MPXV, while a smaller group of vaccinated individuals showed a T-cell-specific response against MPXV.

VACCINES (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Treatment-Emergent Cilgavimab Resistance Was Uncommon in Vaccinated Omicron BA.4/5 Outpatients

Cesare Ernesto Maria Gruber, Fabio Giovanni Tucci, Martina Rueca, Valentina Mazzotta, Giulia Gramigna, Alessandra Vergori, Lavinia Fabeni, Giulia Berno, Emanuela Giombini, Ornella Butera, Daniele Focosi, Ingrid Guarnetti Prandi, Giovanni Chillemi, Emanuele Nicastri, Francesco Vaia, Enrico Girardi, Andrea Antinori, Fabrizio Maggi

Summary: Mutations in the SARS-CoV-2 Spike glycoprotein can affect monoclonal antibody efficacy. Recent findings report the occurrence of resistant mutations in immunocompromised patients after tixagevimab/cilgavimab treatment. Our study retrospectively reviewed 22 immunocompetent patients at high risk for disease progression who received intramuscular tixagevimab/cilgavimab as early COVID-19 treatment and presented a prolonged high viral load. The study highlights the importance of early virological investigation to prevent drug resistance or clinical failures in immunocompetent patients.

BIOMOLECULES (2023)

添加到收藏夹

Article Microbiology

In Vitro and In Vivo Crosstalk between Type I IFN and IL-8 Responses in SARS-CoV-2 Infection

Mirella Biava, Stefania Notari, Germana Grassi, Licia Bordi, Eleonora Tartaglia, Chiara Agrati, Eleonora Cimini, Giuseppe Sberna, Emanuele Nicastri, Andrea Antinori, Enrico Girardi, Francesco Vaia, Fabrizio Maggi, Eleonora Lalle

Summary: COVID-19 patients show over-expression of cytokines, particularly IL-8, which may interfere with the activation of interferon and impair the immune response.

MICROORGANISMS (2023)

添加到收藏夹

Review Infectious Diseases

Antiviral combination therapies for persistent COVID-19 in immunocompromised patients

Daniele Focosi, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, David J. Sullivan

Summary: After the third year of the COVID-19 pandemic, immunocompromised patients face persistent infection and ineffective treatment with standard antiviral monotherapy. Combined antiviral therapies can mitigate these consequences.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

添加到收藏夹

Article Medicine, General & Internal

Timing and Outcomes of Noninvasive Ventilation in 307 ARDS COVID-19 Patients: An Observational Study in an Italian Third Level COVID-19 Hospital

Nardi Tetaj, Pierluca Piselli, Sara Zito, Giada De Angelis, Maria Cristina Marini, Dorotea Rubino, Ilaria Gaviano, Maria Vittoria Antonica, Elisabetta Agostini, Candido Porcelli, Giulia Valeria Stazi, Gabriele Garotto, Donatella Busso, Silvana Scarcia, Assunta Navarra, Claudia Cimaglia, Simone Topino, Fabio Iacomi, Alessandra D'Abramo, Carmela Pinnetti, Gina Gualano, Alessandro Capone, Alberta Villanacci, Andrea Antinori, Fabrizio Palmieri, Gianpiero D'Offizi, Stefania Ianniello, Fabrizio Taglietti, Paolo Campioni, Francesco Vaia, Emanuele Nicastri, Enrico Girardi, Luisa Marchioni

Summary: This study found that NIV failure in COVID-19 ARDS patients is correlated with the severity of the disease. In COVID-19 patients, starting NIV treatment appears to increase its effectiveness and reduce the risk of intubation and/or death for patients with mild ARDS (P/F > 200 mmHg). Additionally, early NIV treatment seems to decrease the risk of ICU mortality at 28 days from ICU admission.

MEDICINA-LITHUANIA (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.